Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market Trends 2022 | Segmentation, Outlook, Industry Report to 2028

The Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market size is expected to grow at an annual average of 4% during 2021-2027. DTP stands for diphtheria, tetanus and whooping cough. The vaccine used for DTP is an immunization drug given initially at 2 years of age to create acquired immunity against DTP (diphtheria, tetanus, and pertussis). Since 1974, the DTP vaccine has been part of the Expanded Program of Immunization (EPI) immunization schedule. DTP as a standalone vaccine was significantly reduced. Increased demand for tetravalent and subsequently pentavalent combination vaccines has contributed primarily to this change. The increased demand for combination products was driven primarily by GAVI (Global Alliance for Vaccines and Immunizations) funding for other DTP-containing vaccines.

The following segmentation are covered in this report:

By Age Group

• Adult
• Pediatrics

By Product Type

• DTaP Vaccines
• TD Vaccines
• Tdap Vaccines

By End User

• Hospitals
• Clinics
• Vaccination Centers

Company Profile

• AJ VACCINES
• BIONET-ASIA
• GLAXOSMITHKLINE PLC (GSK)
• JOHNSON & JOHNSON
• MASSBIOLOGICS
• MEIJI HOLDINGS CO., LTD. (KM BIOLOGICS CO., LTD.)
• MERCK & CO., INC.
• PANACEA BIOTEC LTD.
• SANOFI
• SERUM INSTITUTE OF INDIA PVT. LTD

Scope of the report

The research study analyses the Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market Report

• What was the Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.